Original Article Family/General Practice Osteopathic Medicine
Rethinking length of stay in patients after cardiac surgery: the role of frailty screening

Rethinking length of stay in patients after cardiac surgery: the role of frailty screening

Authors

Yusuf Silva

Yusuf Silva

Hamad Medical Corporation, Seychelles

Corresponding

Published

January 23, 2024

Paper ID

PAP-000041

Status

Published

DOI

10.65712/tmj.test000299

Rethinking length of stay in patients after cardiac surgery: the role of frailty screening

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of length of stay to health systems is substantial. Methods: Eligible participants were patients after cardiac surgery. Results: length of stay occurred in 19% of the intervention group versus 32% of controls. Effects were consistent across prespecified subgroups. Conclusion: Strengths include the sample size and blinded outcome assessment.

Introduction

Earlier studies of frailty screening were small or single-centre. Practice around frailty screening varies widely between centres. Guidelines make only a weak recommendation on frailty screening.

length of stay remains a leading cause of avoidable harm among patients after cardiac surgery. Earlier studies of frailty screening were small or single-centre.

Materials and Methods

Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients after cardiac surgery.

Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation. Eligible participants were patients after cardiac surgery. The primary outcome was length of stay, assessed blind to allocation.

We conducted a randomised controlled trial across 7 centres between 2014 and 2022. Analyses were adjusted for age, sex and baseline severity. We conducted a randomised controlled trial across 8 centres between 2019 and 2023.

Missing data were handled with multiple imputation. The primary outcome was length of stay, assessed blind to allocation. Eligible participants were patients after cardiac surgery.

Results

The adjusted odds ratio was 0.69 (95% CI 0.37 to 0.84). The adjusted odds ratio was 0.39 (95% CI 0.27 to 0.83).

2731 participants were included (median age 47 years). The adjusted odds ratio was 0.75 (95% CI 0.39 to 0.90).

GroupnEvents
Age < 656634
Control15517
Intervention300118
Control4294
Age < 6569636
TABLE 1: Subgroup analysis
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Forest plot of length of stay
Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Distribution of length of stay
Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.38 (95% CI 0.25 to 0.70). 1338 participants were included (median age 74 years). Effects were consistent across prespecified subgroups.

Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.46 (95% CI 0.23 to 0.63).

Discussion

Future work should test frailty screening in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.

These findings suggest that frailty screening is associated with better length of stay in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.

Conclusions

Frailty screening should be considered for patients after cardiac surgery to improve length of stay.

References

1. Herrera Z, Moreau V, et al. An enhanced recovery pathway and time to diagnosis. Diabetes Care. 2021;250(10):181-1324.

2. Andersen E, Kim Q, et al. Point-of-care ultrasound and falls. Crit Care Med. 2019;390(7):650-1358.

3. Nakamura L, Farouk G, et al. Machine-learning triage and falls. N Engl J Med. 2021;182(5):831-1467.

4. Kaur H, Kaur T, et al. Home-based cardiac rehabilitation and length of stay. BMJ. 2023;281(1):697-1793.

5. Herrera Y, Novak P, et al. Tranexamic acid and falls. Diabetes Care. 2016;14(5):258-1555.

6. Herrera I, Ibrahim G, et al. Frailty screening and patient satisfaction. Pediatrics. 2024;224(9):294-1298.

Appendices

Ethics approval: IRB-5405.